A prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint.

A prospective study for the assessment of recurrence risk in stage II colon cancer patients using ColoPrint. - PARSC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31942

Enrollment

100

Registered

2008-10-03

Start date

2008-07-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenocarcinoma of the colon colon cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - > 18 - adenocarcinoma of the colon - stage II (1-III) planned to be treated with radical surgery

Exclusion criteria

Exclusion criteria: - prior malignancy with the exception of basal cell carcinoma or cervical dysplasia - any neo-adjuvant therapy - synchronous tumors

Design outcomes

Primary

Measure	Time frame
• Endpoint: risk assessment by Physician (based on local protocol) in comparison with ColoPrint result • Endpoint: relapse or 3 years disease-free survival (DFS)	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results